Cargando…
Biomarker repurposing: Therapeutic drug monitoring of serum theophylline offers a potential diagnostic biomarker of Parkinson’s disease
Caffeine has been considered a neuroprotective agent against Parkinson’s disease (PD). Recent metabolomic analysis showed that levels of caffeine and its metabolites were decreased in sera from patients with PD compared with those from healthy controls. We focused on theophylline, which is one of th...
Autores principales: | Ohmichi, Takuma, Kasai, Takashi, Kosaka, Tadashi, Shikata, Keisuke, Tatebe, Harutsugu, Ishii, Ryotaro, Shinomoto, Makiko, Mizuno, Toshiki, Tokuda, Takahiko |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6059449/ https://www.ncbi.nlm.nih.gov/pubmed/30044870 http://dx.doi.org/10.1371/journal.pone.0201260 |
Ejemplares similares
-
Cerebral spinal fluid biomarker profiles in CNS infection associated with HSV and VZV mimic patterns in Alzheimer’s disease
por: Shinomoto, Makiko, et al.
Publicado: (2021) -
Serum Levels of Coenzyme Q10 in Patients with Multiple System Atrophy
por: Kasai, Takashi, et al.
Publicado: (2016) -
Plasma neurofilament light chain: A potential prognostic biomarker of dementia in adult Down syndrome patients
por: Shinomoto, Makiko, et al.
Publicado: (2019) -
Quantification of Blood Caffeine Levels in Patients With Parkinson's Disease and Multiple System Atrophy by Caffeine ELISA
por: Ohmichi, Takuma, et al.
Publicado: (2020) -
Amyotrophic lateral sclerosis: Correlations between fluid biomarkers of NfL, TDP-43, and tau, and clinical characteristics
por: Kojima, Yuta, et al.
Publicado: (2021)